Table 1.
Baseline clinical characteristics for all patients treated from 2003 to 2017
| Patients(N = 1,227) | ||
|---|---|---|
| Clinical Characteristic | No | % |
| Age, years | ||
| Mean | 56.2 | |
| Range | 23–86 | |
| Lymphadenectomy | ||
| No | 361 | 29.4 |
| Yes | 866 | 70.6 |
| Mean Number | 23.7 | |
| Range | 1–99 | |
| Pathology type | ||
| Endometrioid Adenocarcinoma | 1137 | 92.7 |
| Nonendometrioid Carcinoma | ||
| Mixed cell carcinoma | 43 | 3.5 |
| Serous carcinoma | 22 | 1.8 |
| Clear cell carcinoma | 16 | 1.3 |
| Undifferentiated carcinoma | 6 | 0.5 |
| Others | 3 | 0.2 |
| Stage(FIGO 2009) | ||
| IA | 566 | 46.1 |
| IB | 500 | 40.7 |
| II | 161 | 13.1 |
| Diameter | ||
| < 2 cm | 141 | 11.5 |
| ≥ 2 cm | 685 | 55.8 |
| Missing | 401 | 32.7 |
| Gradea | ||
| G1 | 395 | 34.7 |
| G2 | 518 | 45.5 |
| G3 | 219 | 19.2 |
| Missing | 6 | 0.5 |
| Myometrial invasion | ||
| < 1/2 | 638 | 52.0 |
| ≥ 1/2 | 581 | 47.4 |
| Missing | 8 | 0.7 |
| Invasion of lower uterine segment | ||
| No | 885 | 72.1 |
| Yes | 342 | 27.9 |
| Involvement of cervix | ||
| No | 975 | 79.5 |
| Yes | ||
| Cervical mucosa | 91 | 7.4 |
| Cervical stromal | 161 | 13.1 |
| Lympho-vascular Space Invasion | ||
| Present | 222 | 18.1 |
| Absent | 1005 | 81.9 |
| Chemotherapy | ||
| No | 997 | 81.3 |
| Yes | 230 | 18.7 |
Abbreviation: FIGO International Federation of Gynecology and Obstetrics
aonly for endometrioid adenocarcinoma